Generative AI can help athletes avoid injuries
Researchers at the University of California San Diego have created a model driven by generative AI that will help prevent injuries in athletes and also aid in rehabilitation… read more.
Researchers at the University of California San Diego have created a model driven by generative AI that will help prevent injuries in athletes and also aid in rehabilitation… read more.
Amneal Pharmaceuticals, Inc. announced that the FDA has tentatively approved the Company’s Abbreviated New Drug Application (ANDA) for beclomethasone dipropionate HFA inhalation aerosol (40 mcg/actuation and 80 mcg/actuation)…. read more.
Researchers report that people drinking three or more alcoholic drinks per day are at a significantly greater risk of intracerebral hemorrhage (a type of stroke caused by bleeding… read more.
GERPAC Congress highlights The successful development of fenfluramine-loaded albumin nanoparticles paves the way for nasal administration of fenfluramine in drug-resistant epilepsy in children. Nasal administration would deliver the… read more.
The management of menopause and perimenopause often presents healthcare professionals (HCPs) with questions that require careful, evidence-based responses. In this interview Dr. Louise Newson, a physician and female… read more.
Insmed announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted a positive opinion recommending approval of its DPP1 inhibitor Brinsupri (brensocatib… read more.
A prospective population-based cohort study of suboptimally active adults (<8,000 steps per day) assessed whether individuals who accumulate their daily steps in shorter or longer bouts are at… read more.
In ongoing efforts to pinpoint the best evidence-based ways to quit smoking, a University of Massachusetts Amherst public health researcher has turned her attention to a tobacco-free product… read more.
Teva Pharmaceutical Industries Ltd. entered into a license agreement with Prestige Biopharma, for the commercialization of Tuznue (trastuzumab), a biosimilar to Herceptin, across a majority of European markets…. read more.
Women living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according… read more.
The federal Food and Drug Administration today approved a new menopause drug that reduces hot flashes and night sweats after the drug was successfully tested at UVA Health… read more.
Pfizer Inc and Astellas announced final overall survival (OS) results from the Phase III EMBARK study evaluating Xtandi (enzalutamide), in combination with leuprolide and as monotherapy, in men with… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.